"We assess the level of tumour necrosis factor alpha (TNF-alpha) in tear fluids and other serum parameters associated with diabetes in different degrees of diabetic retinopathy. We have performed a prospective, nonrandomized, observational study. Study population consisted of 16 healthy subjects (controls) and 32 type 2 diabetic patients: 16 affected by proliferative diabetic retinopathy (PDR) and 16 with nonproliferative retinopathy (NDPR, background\/preproliferative). Body mass index, urinary albumin, blood glucose, HbA1c, and tear levels of TNF-alpha were measured in all subjects. The value of glycaemia, microalbuminurea, and Body mass index in diabetic retinopathy groups were higher than those in control group (P < 0.05). Glycemia in NPDR: 6.6 mmol\/L (range: 5.8-6.3); in PDR: 6.7 mmol\/L (range: 6.1-7.2); in control: 5.7 mmol\/L (range: 4.9-6.1); microalbuminurea in NPDR: 10.6 mg\/L (range: 5.6-20); in PDR: 25.2 mg\/L (range: 17-40); in control: 5.3 mg\/L (range: 2.6-10); Body mass index in NPDR: 26 Kg\/m(2) (range: 20.3-40); in PDR: 28 Kg\/m(2) (range 20.3-52); in control: 21 Kg\/m(2) (range 19-26). The TNF-alpha concentrations in tears increase with the severity of pathology and were lower in control group than in diabetic subjects. In the end, the level of TNF-alpha is highly correlated with severity of diabetic retinopathy and with nephropathy. Tear fluid collection may be a useful noninvasive method for the detection of proliferative diabetic retinopathy."
TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy
COSTAGLIOLA, Ciro;DELL'OMO, Roberto;
2013-01-01
Abstract
"We assess the level of tumour necrosis factor alpha (TNF-alpha) in tear fluids and other serum parameters associated with diabetes in different degrees of diabetic retinopathy. We have performed a prospective, nonrandomized, observational study. Study population consisted of 16 healthy subjects (controls) and 32 type 2 diabetic patients: 16 affected by proliferative diabetic retinopathy (PDR) and 16 with nonproliferative retinopathy (NDPR, background\/preproliferative). Body mass index, urinary albumin, blood glucose, HbA1c, and tear levels of TNF-alpha were measured in all subjects. The value of glycaemia, microalbuminurea, and Body mass index in diabetic retinopathy groups were higher than those in control group (P < 0.05). Glycemia in NPDR: 6.6 mmol\/L (range: 5.8-6.3); in PDR: 6.7 mmol\/L (range: 6.1-7.2); in control: 5.7 mmol\/L (range: 4.9-6.1); microalbuminurea in NPDR: 10.6 mg\/L (range: 5.6-20); in PDR: 25.2 mg\/L (range: 17-40); in control: 5.3 mg\/L (range: 2.6-10); Body mass index in NPDR: 26 Kg\/m(2) (range: 20.3-40); in PDR: 28 Kg\/m(2) (range 20.3-52); in control: 21 Kg\/m(2) (range 19-26). The TNF-alpha concentrations in tears increase with the severity of pathology and were lower in control group than in diabetic subjects. In the end, the level of TNF-alpha is highly correlated with severity of diabetic retinopathy and with nephropathy. Tear fluid collection may be a useful noninvasive method for the detection of proliferative diabetic retinopathy."I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
